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Green fluorescent protein (GFP) has been used extensively since its discovery in the 
1960s to report and visualize gene expression.  For years it has been the only known 
naturally occurring fluorescent pigment that is encoded by a single gene, making it 
extremely useful in various fields of biology, because the expression of this gene 
directly leads to the appearance of the fluorescent green color.  Recently, however, 
many more proteins with similar properties to GFP, and available in a variety of colors, 
have been isolated from the class of marine organisms called Anthozoa, which includes 
the corals.  This increase in the availability of colored proteins in the GFP family in turn 
has expanded the number of available biotechnology applications.  However, some of 
these newly discovered GFP-like proteins do not have wild-type forms that readily allow 
for the creation of fusion proteins, particularly because of oligomerization.  It is widely 
accepted that almost all members of the GFP-family form dimers or tetramers in their 
functional forms.  This study investigates a GFP-like protein, Purple, isolated from two 
species, Galaxea fascicularis and Montipora efflorescens. Purple protein forms 
oligomers when expressed, which would then interfere with the normal expression of a 
protein to be tagged in gene fusion experiments.  We selectively mutated 3 amino acids, 
which we believed were responsible for oligomerization in Purple.  These 3 residues 
were chosen based on sequence similarities to a very similar protein, a mutant form of 
the Rtms5 chromoprotein from Montipora efflorescens. While we had hoped that the 
resulting triple-mutant Purple protein would form monomers in vivo while retaining its 
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purple coloration, this turned out to be incorrect.  The resulting mutants had lost their 
ability to turn purple.  However, we also determined that we had successfully changed 
the oligomerization state of Purple by examining the relative molecular mass of one our 
mutant proteins, which turned out to be half the size of the original purple protein.  It is 
possible that by adding addition mutations in the future, the original spectral properties 




















Green Fluorescent Protein (GFP) has become one of the most widely studied and used 
proteins in biology today.  The protein was originally isolated from the Aequora jellyfish 
in 1962 by Osama Shimimorua as a companion protein to aquorin (Tsien, 1998).  
However, it subsequently took over forty years for the true value of GFP to be fully 
realized, and it was not until 2008 that the Nobel Prize in chemistry was awarded to 
Osamu Shimomura, Martin Chalfie, and Roger Tsien for the discovery and development 
of GFP.  After the discovery of the protein itself, one of the most important subsequent 
findings was that the gene could also be expressed in organisms other than Aequora 
and still maintain its fluorescence (Tsien, 1998).  The significance of this was that the 
gene contained all the necessary information for the synthesis of the chromophore 
without requiring the addition of other enzymes or substrates as is the case with 
fluorescent jellyfish proteins.  Several other genera of marine organisms related to the 
jellyfish were found to have GFP-like proteins, but all of these seemed to have 
chromophores that were external cofactors, such as lumazines or flavins (Tsien, 1998).   
Structure of GFP 
Wild-type GFP is a stable protein consisting of a single chain of 238 residues.  It has 
absorption maxima at both 395 and 475 nm (Ormo, 1996), and an emission peak at 475 
nm (Yang, 1996). The chromophore is a p-hydroxybenzylideneimidazolinone, which is 
formed by residues 65–67: Serine, Tyrosine, and Glycine, respectively, in the protein 
(Tsien, 1998).  The chromophore is formed by autocatylitic cyclicization and oxidation of 
these three amino acids, and excitation is then triggered with a specific wavelength of 
light (Phillips, 2001).   
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After determining the crystal structure of GFP, it was discovered that that the protein 
fold consists of an 11-stranded beta-barrel, with a coaxial helix in the middle.  The 
chromophore forms the central helix (Ormo, 1996). Additionally, there are short helical 
segments at the end of the cylinder formed by the beta-barrel, which form caps.  The 
fluorophore is protected from the outside environment on the central helix within the 
beta barrel.  This barrel with caps essentially forms a can, which does not have any 
holes though which ligands could diffuse through. This structure could explain the 
stability of GFP, including characteristics such as resistance to heat and other 
denaturants (Yang, 1996).   Wild-type GFP folds efficiently around room temperature, 
but this efficiency rapidly declines at higher temperatures.  However, once it is folded 
properly, it can fluoresce at higher temperatures.  Subsequent variants produced by 
mutations have increased the temperature at which GFP is able to fold (Tsien, 1998).   
 
Fig 1.  Barrel structure of GFP.  The chromophore 
is colored green. Adapted from: Matz “Family of 
the Green Fluorescent Protein: Journey to the 
















Modifications to the Original GFP 
The original (wild-type) version of GFP that was isolated from Aqueora had a number of 
problems that had to be corrected to optimize its use in a variety of applications.  The 
formation of the fluorophore was slow, it often formed inactive inclusion bodies in the 
cell, and the fluorescent intensity was low (Phillips, 2001).  Also previously noted were 
the problems GPF had when attempting to fold at higher temperatures.  Thus, attempts 
were made to modify wild-type GFP to correct these problems.  It was found that a 
single amino acid substitution could increase the speed of the fluorophore formation 
from 2 hours to 45 minutes, and additional mutations allowed the protein to fold more 
efficiently at higher temperatures.  Mutants were also created in which two absorbance 
peaks in wild-type GFP were converted to a single absorbance peak.  In combination, 
these mutations were used to create a version of GFP known as enhanced GFP 
(EGFP), characterized by enhanced stability and brightness.  EGFP can be visualized in 
cells at low intensity for several hours with minimal photobleaching (Lippincott-
Schwartz, 2003).  Mutants were also screened for a variety of other desirable 
properties, particularly increased brightness.   
 
Another valuable characteristic in the GFP mutants was color variation. During the 
nineties, in the absence of the discovery of additional, non-green proteins with the same 
properties as GFP, an effort was made to create other colors from the original green-
fluorescent protein isolated from Aequorea victoria.  This resulted in a group of red-
shifted mutants (Delagrave, 1994).  These mutants were created using combinatorial 
mutagenesis and were screened using digital imaging spectroscopy, which allows for 
 8 
the simultaneous screening of thousands of colonies.  These red-shifted mutants have 
excitation maxima about 100 nm higher (490nm) than wild-type GFP (390nm).  This 
difference in excitation maxima means that both of these proteins could be 
simultaneously expressed in the same cell, and still be spectrally separable (Delagrave, 
1994).  Mutational analysis of GFP has created several different isoforms in addition to 
the red-shifted mutants, including proteins that emit a blue-green light, a red-shifted 
variant, and a third variant, which is brighter than the wild-type (Misteli, 1997). These 
proteins were known as blue fluorescent protein (BFP), yellow-fluorescent protein 
(YFP), and cyan fluorescent protein (CFP).   
 
However, none of these GFP variants were able to achieve an emission maxima longer 
than 529nm (Baird, 2000).  There were also other shortcomings that made these mutant 
GFP-variants less than ideal.  For example, the blue variants created in this way were 
dim and photobleached easily (Lippincott-Schwartz, 2003). So, despite these attempts 
to create color variants of GFP, one of the major limits to developing new technology 
has been the limited number of colors available.  At best, the color variations created by 
mutants of GFP have allowed for dual-color labeling in experiments where it is 
necessary to simultaneously track two different proteins.  However, there were not 
enough color differences to allow for triple-color labeling.  The limited number of color 
variants also hinders the use of applications based on fluorescence resonance energy 
transfer (FRET).   FRET technology allows for the study of protein-protein interactions in 
situ (Matz, 2002).   
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Applications of GFP 
GFP is useful for a variety of applications because of its ability to fluoresce when fused 
to a target protein without the addition of any exogenous substrates.  Thus it is often 
used as a reporter gene for studying protein and DNA localization.   Use of GFP as a 
reporter gene enables the study of such things as DNA replication and translation, 
protein export, and signal transduction in living cells.  This can be done in real time, 
allowing the visualization of protein localization (Phillips, 2001).   
 
Other traditional methods of studying protein localization include such techniques as 
immunofluorescent microscopy.  However, this requires the use of antibodies directed 
against the target protein, which may be difficult to obtain.  Additionally, this method 
often requires the cells to be fixed, and thus living cells can’t be used.  Gene fusions 
using GFP have significant advantages over this method.   They are relatively easy to 
construct, have a high level of sensitivity, and do not require invasive sample 
preparation (which would kill the cells) or addition of a substrate to activate the 
fluorescence (Phillips, 2001).  This tool has led to significant discoveries in several 
fields.  For example, as a result of the use of GFP fusion studies in bacteria, the 
previously held concept that bacterial cells had limited cellular organization was 
abandoned in light of the knowledge that there is considerable amount of sequestration 
of molecules into subcellular compartments (Phillips, 2001).  
 
Fluorescent GFP has also been expressed in a number of different organisms besides 
bacteria.  These include yeast, slime molds, plants, Drosophila, zebrafish, and 
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mammalian cells (Yang, 1996).  In fact, one of the first uses of GFP in time-lapse 
microscopy tracked ribonucleoprotein particles moving through developing egg 
chambers of drosophila (Misteli, 1997).  The ability to create a fusion protein with GFP 
allows it to be used as cell lineage tracers, reporters of gene expression, and a measure 
of protein-protein interactions (Yang, 1996).  Additionally, GFP has great potential for 
use in biological screening.  In simple cases, GFP can be fused to the gene of interest, 
and then used to rapidly screen cells to see if they have incorporated the gene.  Other 
examples include more complex cases in which GFP has been used to screen 
embryonic stem cells and transgenic animals.  Several studies have already used GFP 
to screen mouse embryos, resulting in a high yield of transgenic mice with low toxicity 
(Misteli, 1997).  
 
The creation of gene fusions with GFP is relatively simple.  A variety of commercially 
available vectors are available with different GFP variants.  The general strategy for 
constructing GFP fusion proteins is to engineer restriction enzymes sites into both GFP 
and the target protein DNA sequence to create a recombinant plasmid.  The GFP 
reporter gene can be added to either end of the target gene.  However, if GFP is being 
attached to a membrane protein, GFP must be added to the cytoplasmic side (Phillips, 
2001). It must be noted that the fusion of GFP to a target protein can alter both the 
protein’s function and localization, although there are many cases where it does neither 




The Search for GFP-like Proteins 
Since the discovery of GFP in the early 1960s, the search has been on for other 
proteins like it.  Recall that GFP is unique in its ability to produce green color from a 
single gene without the help of additional enzymes and cofactors.  Thus, there was 
much interest in discovering other proteins with this property.  Since GFP had originally 
been identified in the bioluminescent jellyfish Aequorea victoria, scientists naturally 
searched for similar proteins in similar (bioluminescent) organisms.  However, many 
other bioluminescent organisms that were examined, such as other jellyfish and 
copepods, were not homologous to Aequorea, and in fact had evolved recently from 
unrelated lineages (Matz, 2002).    Thus, GFP remained the only known protein to 
possess this unique ability until 1999.  It wasn’t until the search parameters were 
modified that other members of the GFP family started to turn up (See Fig 3). The idea 
emerged that GFP-like proteins might not all be fluorescent, but might simply have a 
high ability to absorb light (Matz, 2002).  This new criteria led researchers to examine 
non-florescent organisms, such as the Anthozoa class containing brightly colored coral.  
And thus, new proteins, similar to GFP, started to appear everywhere.   
 
To date, there have been over 30 significantly different GFP-like proteins that have 
been cloned and added to the sequence database.  Of these, 6 are from bioluminescent 
organisms.  The rest are all from Anthozoa, and are fluorescent but not bioluminescent 
(Matz, 2002).  These proteins can be divided into 4 main color classes: green, yellow, 
orange-red, and non-fluorescent purple-blue (Alieva, 2008).  All of these classes have 
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maintained the same structure as the original GFP isolated from Aequorea victoria, 
consisting of a beta-barrel (See Fig 2).   
 
 
Fig 2. The beta-barrel 
structure in GFP-like 
proteins, and the pre-
cyclization state of the 










In addition to the discovery of fluorescent, but non-bioluminescent, GFP-like proteins, it 
has also been shown that there are non-fluorescent GFP-like proteins that control 
coloration.  Such an example is seen in the sea anenome Anemonia sulcata, which 
expresses a purple, non-fluorescent, GFP-like homolog in the tips of its tentacles 
(Lukyanov, 2000). The discovery of GFP-like proteins available in a multitude of colors 
has made it possible to greatly expand the previously developed technology, as well as 
develop new technologies for use with such proteins. The availability of red GFP-like 
proteins alone has improved the fluorescence in animal tissues, which typically is 
greatly reduced when using longer wavelength colors (Matz, 2002).  Also, the selection 
of a variety of different colors allows for the use of multi-color labeling that was 
previously limited to, at most, 2 colors.  It is now possible to use up to 4 colors 




Fig 3. Spectral Characteristics of the GFP Family.  Figure borrowed from Pakhomov, 
“GFP Family: Structural Insights into Spectral Tuning.” (2008.)     
 
Limitations Associated with GFP-like Proteins 
While a variety of GFP-like proteins have been, and are being, discovered, there are a 
number of different requirements that are necessary for these proteins to be useful in 
biotechnology applications.  Additionally, different types of experiments will need 
different types of proteins.  Thus, while it may at first be unclear as to why such a large 
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variety of GFP-like proteins are desirable, it becomes more apparent when the different 
parameters of the experiment are examined.  First, the GFP-like protein must not be 
toxic to the cells it is expressed in, and it must be bright enough to be detected and 
imaged.  The brightness of a GFP-like protein is determined by several factors, 
including the extinction coefficent and quantum yield.  Additionally, the imaging 
equipment used must be a good match for a given protein. The protein must also be 
stable, and not interfere with other cellular events (Shaner, 2005).  And, as mentioned 
above, the GFP-like protein chosen for fusion experiments must not oligomerize.  In 
addition to being problematic in fusion proteins, tetrameric proteins have often been 
found to be toxic to bacteria, especially in cases when there is a significant amount of 
aggregation.  However, monomeric fluorescent proteins are usually not toxic to cells 
(Shaner, 2005).  Another consideration is the temperature range in which the protein is 
able to mature.  Many experiments are conducted at 37°C, but this is not the optimal 
maturation temperature for many GFP-like proteins.  Photostability is another important 
consideration in choosing a fluorescent protein, because there is a significant amount of 
photobleaching between otherwise very similar proteins.  This is a particularly important 
characteristic when an experiment requires a large number of pictures to be taken 
(Shaner, 2005).  Currently, one of the best monomers available in the far-red (purple) 
spectral class, in terms of brightness and photostability, is mPlum.  However, it is 
significantly less bright than many of the shorter-wavelength proteins (Shaner, 2005).  
 
Considering these requirements, many of the newly discovered GFP-like proteins are 
not without their limitations.  Most of them have not been isolated in a “readily usable 
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state” because they form oligomers when expressed.  Recall that an important 
requirement when choosing a fluorescent protein for use as a fusion protein is that the 
fluorescent protein must not oligomerize (Shaner, 2005).  This is a significant limitation 
because it both hinders their usefulness in FRET technology as well labeling proteins in 
situ (Matz, 2002).  However, GFP-like proteins that form oligomers are still useful as 
reporter genes, selection markers, and biosensors (Shaner, 2005).  Additionally, while a 
number of different-colored proteins have been discovered, most of these center around 
two regions of the visible light spectrum: cyan-green (470-520 nm), and orange-red 
(570-600 nm).  This leaves several notably large gaps including blue-purple and yellow-
orange. However, these gaps are expected to become smaller and smaller as more 
coral proteins are screened and studied (Matz, 2002).   
 
A particularly good example is DS Red, which is a GFP-like fluorescent protein isolated 
from the genus of coral Discosoma.  It has generated excitement as a fusion protein 
because of its high extinction coefficient, as well as its resistance to extreme pH and 
photobleaching.  Additionally, its natural emission maxima of 583nm can be shifted to 
602nm by a single point-mutation.  This is significant because 583nm is the longest 
reported wavelength for a wild-type, spontaneously fluorescent protein.  However, it is 
severely limited in its use in biotechnology applications by its strong tendency to 





Fig 4.  Tetrameric form of DsRed. Adapted from: 
Matz “Family of the Green Fluorescent Protein: 





Focus of This Study: Purple Protein 
The protein I am working on, known as “Purple”, has been isolated from Galaxea 
fascicularis and Montipora efflorescens.  However, Purple forms tetramers in vivo, 
which is an undesirable property when using the protein in fusion experiments.  Our 
goal was to monomerize purple via site-directed mutagenesis of 3 amino acids: #102 
(Threonine to Lysine), #149 (Arginine to Glutamic Acid), and #158 (Phenylalanine to 
Lysine). Because neither the crystal or solution structure of Purple has been 
determined, we depended on sequence data to compare Purple with another similar 
GFP-like protein, in which the 3-dimensional structure had been analyzed, and the 
protein had been successfully converted from a tetramer to a monomer.  A mutant form 
of the Rtms5 chromoprotein from Montipora efflorescens (see Fig 5) was chosen for this 
purpose.  Sequence comparisons indicated which of the amino acids in Purple we 
would most likely need to mutate based on homology to the 3 amino acids, which are 
responsible for allowing the protein to form oligomers (see Fig 6). Amino acid 149 of 
purple was chosen because in the homologous residue of Rtms5, this amino acid forms 
a salt bridge between subunits of the tetramers.  Amino acids 102 and 158 were chosen 




Fig 5. Structure of mutant form of 
the Rtms5 chromoprotein from 
Montipora efflorescens. Figure 
created by Eric J. Montemayor 










Fig 6. Interaction of 
residues to allow 
oligomerization in Purple. . 
Figure created by Eric J. 
Montemayor (University of 






In order to change these three amino acids via site-directed mutagenesis, the genes for 
the purple proteins were inserted into a plasmid, which then allowed us to mutagenize in 
the bacterial overexpression plasmid.  We then sequenced each mutant to confirm that 
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the targeted amino acid had been appropriately changed and that the rest of the gene 
was not mutagenized.  In this way, we first generated a set of 3 single-mutants, which 
we then used to produce a set of 3 double-mutants.  Finally, we used the double 
mutants to produce a single triple-mutant.   
 
After generating the triple mutant of Purple, we assessed the resulting protein to 
determine whether it was still being expressed, and if it was soluble.  Additionally, we 
then had to determine whether we had successfully created a monomer and if the 
mutant had maintained its ability to turn purple.   To determine if our mutants had 
indeed been converted to a monomeric form, we purified the mutants and used size 
exclusion chromatography to determine its relative molecular weight.  It was even 
simpler to ascertain whether or not mutant-Purple would still express the purple color:  
we simply transformed the plasmid containing the mutant gene and observed the 











Materials & Methods 
A copy of Purple was obtained from Dr. Mikhail V. Matz (University of Texas at Austin).  
This copy of Purple had been inserted into both the pET16b and pET22b plasmids, 
which contain the gene for ampicillin resistance. Additionally, a His-tag had been added 
to the C-terminal of Purple to allow for purification.  (See Appendix for the sequence of 
Purple.)  
Site-Directed Mutagenesis  
PCR: Polymerase Chain Reaction (PCR) was used to perform site-directed 
mutagenesis on the Purple gene.  Each of the 3 sets of mutagenesis primers was used 
sequentially to change a single amino acid. (See appendix for primer sequences.)   This 
was performed in 50µL reactions consisting of 100ng of template DNA.  The template 
for the first round of PCR reactions was Purple in either the pET16b or pET22b plasmid.  
Single mutants were then used as templates to create double mutants, and the double 
mutants were used to create the triple mutant.  The PCR reaction included: 1X reaction 
buffer, 2.5 units Pfu DNA polymerase, 0.25 mM dNTPs, 125ng forward primer, and 
125ng reverse primer.  PCR cycling was for 1 minute at 95°C and then 18 cycles of: 
95°C for 50 seconds, annealing at 57.6°C (a gradient of temperatures consisting of 
68°C, 63.3°C, 57.6°C, and 55.0°C was used if 57.6°C failed to produce a significant 
amount of product) for 50 seconds, and polymerization at 70°C for 9.5 minutes.  These 
18 cycles were followed by 7 minutes at 70°C and then held at 4°C.   
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Digestion: After the PCR reaction was completed, template DNA was digested by 
adding 10 units of the restriction enzyme DpnI.  This was then incubated in a 37°C 
water bath for 90 minutes.   
 
Analytical Gel: To confirm that the plasmid had been amplified, 10µL of each reaction 
was added to 2µL 5x loading buffer and electrophoresed through a 1% analytical 
agarose gel containing ethidium bromide for 60 minutes at 100V in 1X Tris-Acetate-
EDTA buffer. 
Cloning and Purification 
Transformation into XL-10 Gold: Each PCR reaction was transformed into XL-10 Gold 
competent cells.  This was done by adding 15µL of the PCR reaction to 100µL thawed, 
competent cells and incubating on ice for 30 minutes.  The transformation was plated on 
2XYT plates containing ampicillin and incubated at 37°C overnight.   
 
Miniprep: Isolated colonies were then selected and grown in 3 mL 2XYT cultures 
(containing 0.15 mg of ampicillin per 1 mL of culture) and grown overnight in a shaking 
incubator at 37°C.  These cultures were then purified to extract the pET16b or pET22b 
plasmid using the QIAGEN Spin Miniprep Kit following the manufacturer’s instructions 
and eluting with 75 µL of elution buffer.   
 
Digestion: A diagnostic digest was then performed to confirm that the proper plasmid 
resulted from the PCR mutagenesis.  The digest was performed with 3 µL of each 
plasmid miniprep in 10 µL reactions containing 3 units of restriction enzyme PvuII in 1X 
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NEB Buffer 2 and ddH2O.  This digest was then incubated in a water bath at 37°C for 1 
hour.   
 
Analytical Gel: All 10 µL of the digestion were then added to 2µL 5x loading buffer and 
electrophoresed through a 1% analytical agarose gel containing ethidium bromide for 60 
minutes at 100V in 1X Tris-Acetate-EDTA buffer.  DNA concentrations of the plasmids 
were determined using a Nanodrop device. 
Sequencing of Purple Mutants 
To confirm that the desired mutation had been successfully made, 500ng of each 
mutant plasmid was sequenced by the University of Texas ICMB sequencing core 
facility.  If the correct mutation was found to be in Purple, then this mutant plasmid was 
then used as the template in the next PCR reaction to add additional mutations.  This 
cycle was repeated until all 3 mutations had been inserted to produce the triple-mutant 
of Purple. 
Assessment of Purple Color 
Transformation into BL21: After successfully creating the triple mutant of Purple, we 
then had to assess each of the mutant’s ability to produce color.  Each mutant of Purple 
was transformed into BL21 cells by adding 1 ng of the mutant Purple plasmid to 25 µL 
BL21 cells and incubating for 30 minutes on ice.  This was then plated on 2XYT plates 
containing ampicillin and incubated overnight at 37°C.  This produced a set of plates 
containing each mutant in BL21 cells, which could then be used to inoculate subsequent 
cultures.   
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Cultures of BL21: Isolated colonies of the triple mutants were then used to inoculate 5 
identical 3 mL cultures of 2XYT (containing 0.15 mg of ampicillin per 1 mL of culture).  
These cultures were then incubated overnight at 37°C in a shaking incubator.  
Additionally, 5 identical 3 mL cultures of 2XYT (containing 0.15mg of ampicillin per 1 mL 
of culture) were also inoculated with the un-mutated Purple to serve as a positive 
control.  These cultures were then diluted to an OD of 0.1, as measured by a 
spectrophotometer, in 10 mL 2XYT (containing 0.15mg of ampicillin per 1 mL of 
culture).  This 10 mL set of cultures was then incubated at 37°C in a shaking incubator 
until they reached an OD of 0.45.  At this point, the 5 cultures of both the triple mutant 
and the Purple control were induced to produce Purple with varying concentrations of 
IPTG: 0.05mM, 0.10mM, 0.25mM, 0.50mM, and 1.00mM.  The cultures were then 
incubated at 37°C in a lighted, shaking incubator overnight and assessed for purple 
coloration by visual examination the next day. 
Protein Purification 
Cultures:  3 mL cultures of 2XYT (containing 0.15 mg of ampicillin per 1 mL of culture) 
were inoculated with the single mutants of Purple and the triple-mutant of Purple. A 
culture of the un-mutated copy of Purple was also grown.  These cultures were grown at 
37°C in a shaking incubator overnight.  2 ml of each culture were then used to inoculate 
200 ml cultures of 2XYT (containing 0.15 mg of ampicillin per 1 mL of culture) and then 
grown at 37°C in a shaking incubator until an OD of 0.3 was reached.  At this point, 
each culture was induced with a concentration 0.05 mM IPTG and then incubated at 
37°C in a lighted, shaking incubator overnight.  The 200 mL cultures were centrifuged at 
5000 rpm for 10 minutes to pellet the cells.  Pellets were re-suspended in 15mL of 20 
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mM NaPO4 (pH7), 200 mM NaCl solution. Re-suspended pellets then underwent 4 
rounds of freezing in liquid nitrogen followed by thawing in a 2°C water bath.  Cells were 
then subjected to sonification for 5 cycles involving 15 seconds of sonification at power 
level 7, and 45 seconds cooling in ice water in between cycles.  After sonification, 1.5 
mL of 10% Triton X-100 was added to each sample and then centrifuged at 15,000rpm 
for 20 minutes.  Pellets were discarded. 
 
Ni-NTA Purification:  The His-tag allowed us to use Ni-NTA purification to capture the 
protein.   The supernatant containing the soluble Purple protein was run through BioRad 
Poly-Prep Chromatography Columns.  Columns had been prepared by adding 200 µl  
NiNTA (beads) to each column followed by 10mL of solution (20 mM NaPO4 pH 7.0, 
200mM NaCl, and 10 mM β-mercaptoethanol).  After chromatography, each column 
was washed 3 times with 10 mL of wash buffer (20mM NaPO4 pH7, 200 mM NaCl, 10 
mM  β-mercaptoethanol, 25 mM imidazole).  Each column was then eluted 5 times with 
200 µL elution buffer (20 mM NaPO4 pH 7.0 200 mM NaCl, 300 mM imidazole).   
 
Gel Analysis: Samples were then prepared by adding 20 µL 2X LDS buffer to 2µL of the 
whole-cell sample, 2 µL of the supernatant sample, and 2 µL of the flow-through sample 
from each mutant.  4 µL of these samples were electrophoresed on an SDS-PAGE gel.  
5µL of the 2X LDS buffer was added to 5µL of elution fractions 2 and 3 from each 
mutant, and this was electrophoresed on the SDS-PAGE gel.  Invitrogen BenchMark 
Protein Ladder was used as a size standard.  The protein gel was run in 1X MES SDS 
Page buffer at 200 V for 41 minutes and fixed for 15 minutes in 50% MeOH, 12% HoAc 
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solution on a shaker. After fixing the gel, it was then washed twice for 5 minutes in 
d2H2O on the shaker prior to staining with Coomassie Blue G250.     
Sephadex S200 Gel Filtration Column 
The Sephadex S200 Column on a BioRad Biologic LP chromatography system was 
used to separate the purified proteins by relative molecular weight.  A total of sixty 2.5 
ml elution fractions were collected from each sample.  
Dot Blot 
Nitrocellulose paper was prepared for the dot blot by soaking in water for 5 minutes, 
followed by soaking in TBS solution (20mM Tris pH 7.5, 150mM NaCl) for 5 minutes.  
The membrane was then inserted into a minifold apparatus, and 250 µL of every 3rd 
fraction of each sample was run through under vacuum suction.  10µL of the whole cell 
sample of Purple from the Ni-NTA purification was loaded into the last well to serve as a 
control.  Preparation and visualization was done according to the instructions for 



















Site-Directed Mutagenesis: pET16b 
Mutants were first created using Purple in a pET16b vector.  Thus, we obtained a 
number of different single, double, and triple mutants (See Table 1).  Some of the 
mutations required slightly different annealing temperatures in the PCR reaction.  Note 
that on each figure, mutation 1 refers to amino acid 102, mutation 2 refers to amino acid 
149, and mutation 3 refers to amino acid 158. 
Table 1.  PCR reaction conditions for each mutant in pET16b. 
Vector Mutant Annealing 
Temperature (°C) 
pet16b 2 56.7 
pet16b 1.2 56.7 
pet16b 2.3 56.7 
pet16b 1.2.3 68.0 
 
Fig 7.  PCR with each 
single mutant in pET16b 
at 57.6°C annealing 
temperature.  From the 
left: pET16b template, 
7.5µL 1KB ladder, 
mutation 1, mutation 2, 
mutation 3, and controls 








Fig 8.  PCR of mutations 1, 1.2, 3, and 2.3 in pET16b. Far left and right on each gel is 
7.5µL of 1 Kb ladder.  Mutations from left to right include mutation 1 (gradient of 
temperatures: 45°C, 49°C, 57.6°C, 61.2°C, 65°C and control), mutation 1.2 (and 
control), mutation 3 (gradient of temperatures: 45°C, 49°C, 57.6°C, 61.2°C, 65°C and 
control), and mutation 2.3 (and control). 
  
Additionally, we originally tried PCR with both Taq DNA polymerase, Pfu DNA 
polymerase, or a mixture of the 2 enzymes, and found that Pfu DNA polymerase alone 
worked the best (See Fig 9).  Thus all PCR reactions were done using the polymerase 
Pfu DNA polymerase. 
  Fig 9 (Left). Gradient of PCR 
with a single mutation using Taq, 
Pfu, and a mixture of both.  Left to 
right: 7.5µL 1Kb Ladder, Taq 
(gradient of temperatures: 65°C, 
61.2°C, 57.6°C, 49°C, 45°C), Pfu 
(gradient of temperatures: 
57.6°C, 49°C, 45°C), Mix 45°C, 





After transforming and cloning the PCR for each mutant, the resulting cloned DNA was 
digested with restriction enzyme PvuII and run on an agarose gel.  This allowed us to 
determine if the proper bands were present (see Fig 10).  However, this technique only 
helped to identify if the clone contained the pET plasmid, but did not indicate if the 
proper mutation had been made.  Clones that displayed the correct bands on the gel 
were thus sequenced to see if they contained the correct mutation.  The sequence of 
Purple with each mutation added can be found in the appendix.  We were only able to 
generate one single mutant, mutant 1.  However, we used mutant 1 to generate double 
mutants 1.2 and 2.3.  We then used these to create the triple mutant.   
 
Fig 10. PvuII digestion of 
mutant 1, 2, and 3 
clones.  Left to right: 7.5 
µL 1 Kb ladder, 4 clones 
of mutant 1, 4 clones of 
mutant 2, and 4 clones 







After generating the triple mutant, we then tried to transform each mutant into cells lines 
to express Purple.  The first cell line we chose was Rosetta Blue DE3.  However, when 
the mutants and control were transformed and plated onto plates containing IPTG, the 
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cells failed to grow.  We thought it might be the case that the IPTG, which was meant to 
induce the expression of Purple, was preventing the cells from growing.  To rule out this 
possibility, we grew cultures of the control and mutant, which had been transformed into 
Rosetta Blue DE3, to an OD of 0.3 and then induced these with 0.5 mM IPTG.  These 
cells failed to express Purple. This caused us to re-evaluate the compatibility of Purple 
and the pET16b vector, and thus we chose to recreate the mutants of Purple in a 
pET22b vector.  
Site-Directed Mutagenesis: pET22b 
Mutants were generated in the pET22b vector using the same method used for the 
pET16b vector.  Thus, we were able to generate a complete set of single mutants (1, 2, 
3), 2 double mutants (1.2, 1.3) and the triple mutant (1.2.3).  See table 2 for reaction 
conditions below.  
Table 2. PCR reaction conditions for mutants in pET22bb. 
Vector Mutant Annealing 
Temperature (°C) 
pet22bb 1 56.7 
pet22bb 2 56.7 
pet22bb 3 56.7 
pet22bb 1.2 56.7 
pet22bb 1.3 56.7 
pet22bb 1.2.3 56.7 
 
Figure 11.  PCR of mutants in pET22b. Left to 
right: 7.5µL 1 KB ladder, mutant 1.2, mutant 
2.3, mutant 1.2.3, control: mutant 1.2, control: 







 Figure 12.  PvuII digest of 
mutant clones in pET22b.  
Left to right: 7.5µL 1 KB 
ladder, Purple in pET22b, 4 
clones of mutant 1, 4 clones 










After creating the set of mutations in pET22b, we then transformed all of the mutations 
from both plasmids (pET16b and pET22b) into BL21 cells. It turned out that Purple was 
strain specific, meaning that we had not been able to express it in the Rosetta Blue DE3 
cells because they were the wrong strain, rather than because the plasmid (pET16b) 
was wrong.  In order to determine the concentrations of IPTG necessary for the cells to 
express purple, we grew cultures of both the Purple control and the triple mutant to an 
OD of 0.45, and then induced them with different concentrations of IPTG: 0.05 mM, 0.10 
mM, 0.25 mM, 0.50 mM, 1.00 mM.  After letting the cultures continue to grow overnight, 
we found that the Purple control expressed the purple color at all concentrations, and 
the triple mutant did not turn purple at any concentration.   
Protein Purification 
Mutant 2 consistently failed to grow in culture, and thus was not purified.  However, 
cultures of mutant 1, mutant 3, and the triple mutant were purified.  After separating out 
the protein using Ni-NTA purification, we could visibly see purple coloration in the 
fractions of the control (un-mutated Purple), as well as mutant 1.  Gels were run 
containing different fractions of each sample, including the whole cell (prior to 
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centrifugation), soluble protein (supernatant after centrifugation), flow through (protein 
from the sample that did not remain on the column), and fractions 2 and 3 of the 
elutions.  These gels confirmed that there were strong and clearly identifiable bands in 
the eluted fractions of the mutants that matched the bands in the control Purple.   
 
 
Fig. 13.  Protein gel of fractions from Ni-NTA purification.  Each set of mutants contains 
samples, (left to right) of the whole cell, soluble, flow through, fraction 2, and fraction 3. 
The protein band of interest has been circled (red). 
Left gel: Invitrogen BenchMark Protein Ladder, Purple control, mutant 1. 
Right gel: Invitrogen BenchMark Protein Ladder, mutant 3, triple mutant. 
 
By combining data from the Sephadex gel filtration column and the dot blot test, we 
determined that both the control Purple and mutant 1 eluted at ~50.0mL.  The dot blot of 
Purple and mutant 1 confirm that they both eluted in the same fraction (Fig 15: circled 
green).  The second peak on the dot blot of the control Purple, which did not show up 
on the graph from the gel filtration column, is most likely degraded protein as it 
corresponds to the size of small peptides (Fig 15: circled blue). By comparison with a 
size standard, 50.0 mL corresponds to a size of 65kD.  By contrast, mutant 3 eluted at 
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~64.0 mL, which corresponds to ~32kD (Fig 15: circled yellow).  Unfortunately, there 
was insufficient material for the gel filtration column of the triple mutant to give a clear 
peak.  This was confirmed by the dot blot, which indicated that there were no fractions 
of the triple mutant strong enough to be distinguished from background.  
 





Fig. 15.  Dot blot of every 3rd elution fraction from Sephadex gel filtration. 
Row 1-2: Purple control. 
Row 3-4: Mutant 1. 
Row 5-6: Mutant 3. 
Row 7-8: Triple Mutant. 

























In summary, this study focuses on a member of the GFP-family, Purple protein, recently 
discovered by Dr. Mikhail V. Matz.  Very little is known about the 3-dimensional 
structure of the protein.  However, it is commonly believed that almost all members of 
the GFP-family naturally occur as oligomers, with most being found as tetramers.  
Because we had no reason to believe that Purple would not follow the same pattern as 
similar GFP-like proteins, in addition to early experiments conducted by Dr. Matz, we 
assumed that Purple would also form tetramers.  This is an undesirable property for 
Purple to have, in terms of the possible biotechnology applications of the protein.   
 
Thus, the goal of this study was to monomerize purple via site-directed mutagenesis of 
3 amino acids.  Additionally, it was our hope that the monomerized Purple protein would 
retain its ability to produce the color purple when expressed.  Based on sequence 
similarities to a very similar protein, amino acids 102, 149, and 158 were chosen as 
mutations that were likely to produce monomeric Purple.   
 
After analyzing the resulting mutants, the data indicates that mutating amino acid 102 
did not affect the oligomerization state of Purple.  However, it clearly affected the 
spectral properties of Purple, as it was no longer able to produce purple coloration.  
Interestingly, the 65kD relative molecular mass that characterizes both Purple and the 
version of Purple with a mutation in residue 102 indicates that Purple might actually 
occur naturally as a dimer, rather than as a tetramer as was previously thought.  We 
could not determine the oligomerization state of Purple with the mutation of amino acid 
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149, because this mutant repeatedly failed to grow in cultures.  However, based on that 
piece of information alone, it is unlikely that this mutation would be successful in 
producing a stable monomer that still expressed Purple.  Finally, by mutating amino acid 
158, the oligomerization state of Purple seems to have been changed.  A size of 32kD 
indicates that this mutant is half the size of wild-type Purple.   
 
If we believe that Purple is indeed a dimer, then we have successfully monomerized 
Purple with this mutation.  However, even with the more conservative assumption that 
Purple is naturally a tetramer, we still have successfully changed the oligomerization 
state of Purple with this mutation, which is a very useful piece of information to make 
future alterations to the protein.  Unfortunately, this mutation has affected the spectral 
properties of Purple, effectively knocking out its ability to produce color.  While we were 
not able to draw any conclusion as to the oligomerization state of the triple-mutant from 
the purification and column chromatography experiments, it is likely that this mutant has 
similar properties to the version with the mutation in residue 158.  It is possible, 
however, that the expression of Purple in the triple mutant is hindered by the mutation in 
residue 149, which seems to have adversely effected the single-mutant containing that 
particular mutation (mutant 2). 
 
Future Directions: The results of this study have established a clear groundwork for 
future experiments on Purple.  For one, it would be desirable to determine the wild-type 
oligomerization state of Purple, through such techniques as analytical ultracentifugation.  
This would help to definitively ascertain if mutating residue 158 has produced a 
 35 
monomer or a dimer.  Additionally, now that the oligomerization state of Purple has 
been altered, it may be possible to recover the original spectral properties of the protein 
by performing mutational screens of this mutant.  In this way, the original goal of 
creating a monomeric Purple protein may still be achieved, despite the fact that the 






















Primer Sequences.  Note: lower case letters represent mutations. 
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